Undisclosed healthcare focused fund

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Mar 1, 2021	Gyroscope Therapeutics	$150.0M Series C	Forbion	Abingworth, Cambridge Innovation Capital, Krishna Yeshwant, Sofinnova Investments, Westlake Village BioPartners, Fosun Pharma, Chris Hollowood, Tetragon Financial Group, T. Rowe Price Associates

Total Raised

N/A

Valuation

N/A